40 participants
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-08-17
- Start Date:
- 2025-09-22
- Completion:
- 2029-12-31
Conditions
- Non-small Cell Lung Cancer (NSCLC)
- Anaplastic Lymphoma Kinase (ALK) Positive
Interventions
- DRUG
No Results Yet